491 related articles for article (PubMed ID: 26601964)
1. Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sahebkar A; Simental-Mendía LE; Guerrero-Romero F; Golledge J; Watts GF
Curr Pharm Des; 2016; 22(5):595-608. PubMed ID: 26601964
[TBL] [Abstract][Full Text] [Related]
2. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
Nicholls SJ; Brewer HB; Kastelein JJ; Krueger KA; Wang MD; Shao M; Hu B; McErlean E; Nissen SE
JAMA; 2011 Nov; 306(19):2099-109. PubMed ID: 22089718
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, tolerability, and pharmacokinetic profile of evacetrapib administered as monotherapy or in combination with atorvastatin in Japanese patients with dyslipidemia.
Teramoto T; Takeuchi M; Morisaki Y; Ruotolo G; Krueger KA
Am J Cardiol; 2014 Jun; 113(12):2021-9. PubMed ID: 24786356
[TBL] [Abstract][Full Text] [Related]
4. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sahebkar A; Beccuti G; Simental-Mendía LE; Nobili V; Bo S
Pharmacol Res; 2016 Apr; 106():37-50. PubMed ID: 26875640
[TBL] [Abstract][Full Text] [Related]
5. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients.
Banach M; Dinca M; Ursoniu S; Serban MC; Howard G; Mikhailidis DP; Nicholls S; Lip GYH; Glasser S; Martin SS; Muntner P; Rysz J; Toth PP; Sahebkar A;
Pharmacol Res; 2016 Sep; 111():343-356. PubMed ID: 27350264
[TBL] [Abstract][Full Text] [Related]
6. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
Lincoff AM; Nicholls SJ; Riesmeyer JS; Barter PJ; Brewer HB; Fox KAA; Gibson CM; Granger C; Menon V; Montalescot G; Rader D; Tall AR; McErlean E; Wolski K; Ruotolo G; Vangerow B; Weerakkody G; Goodman SG; Conde D; McGuire DK; Nicolau JC; Leiva-Pons JL; Pesant Y; Li W; Kandath D; Kouz S; Tahirkheli N; Mason D; Nissen SE;
N Engl J Med; 2017 May; 376(20):1933-1942. PubMed ID: 28514624
[TBL] [Abstract][Full Text] [Related]
7. Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.
Simental-Mendía LE; Simental-Mendía M; Sánchez-García A; Banach M; Serban MC; Cicero AFG; Sahebkar A
Lipids Health Dis; 2019 Apr; 18(1):88. PubMed ID: 30954082
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib Administered as Monotherapy in Japanese Patients With Primary Hypercholesterolemia.
Teramoto T; Kiyosue A; Iimura T; Takita Y; Riesmeyer JS; Murakami M
Circ J; 2017 Oct; 81(11):1686-1692. PubMed ID: 28652529
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial.
Nicholls SJ; Ray KK; Ballantyne CM; Beacham LA; Miller DL; Ruotolo G; Nissen SE; Riesmeyer JS;
Atherosclerosis; 2017 Jun; 261():12-18. PubMed ID: 28412650
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Fogacci F; Ferri N; Toth PP; Ruscica M; Corsini A; Cicero AFG
Drugs; 2019 May; 79(7):751-766. PubMed ID: 30989634
[TBL] [Abstract][Full Text] [Related]
11. Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults.
Suico JG; Wang MD; Friedrich S; Cannady EA; Konkoy CS; Ruotolo G; Krueger KA
J Pharm Pharmacol; 2014 Nov; 66(11):1576-85. PubMed ID: 24961753
[TBL] [Abstract][Full Text] [Related]
12. The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis.
Maierean SM; Serban MC; Sahebkar A; Ursoniu S; Serban A; Penson P; Banach M;
J Clin Lipidol; 2017; 11(6):1393-1406. PubMed ID: 28887086
[TBL] [Abstract][Full Text] [Related]
13. A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.
Small DS; Zhang W; Royalty J; Cannady EA; Downs D; Friedrich S; Suico JG
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):483-9. PubMed ID: 25736283
[TBL] [Abstract][Full Text] [Related]
14. Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials.
Simental-Mendía LE; Pirro M; Gotto AM; Banach M; Atkin SL; Majeed M; Sahebkar A
Crit Rev Food Sci Nutr; 2019; 59(7):1178-1187. PubMed ID: 29185808
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia.
Teramoto T; Kiyosue A; Iimura T; Takita Y; Riesmeyer JS; Murakami M
Circ J; 2017 Dec; 82(1):183-191. PubMed ID: 28768921
[TBL] [Abstract][Full Text] [Related]
16. Cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia: a systematic review and meta-analysis.
Li C; Zhang W; Zhou F; Chen C; Zhou L; Li Y; Liu L; Pei F; Luo H; Hu Z; Cai J; Zeng C
PLoS One; 2013; 8(10):e77049. PubMed ID: 24204732
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations.
Serban MC; Sahebkar A; Dragan S; Stoichescu-Hogea G; Ursoniu S; Andrica F; Banach M
Clin Nutr; 2016 Aug; 35(4):842-51. PubMed ID: 26433766
[TBL] [Abstract][Full Text] [Related]
18. The effects of green coffee bean extract supplementation on lipid profile in humans: A systematic review and meta-analysis of randomized controlled trials.
Ding F; Ma B; Nazary-Vannani A; Kord-Varkaneh H; Fatahi S; Papageorgiou M; Rahmani J; Poursoleiman F; Júnior Borges do Nascimento I; Li H; Han D; Wang D
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):1-10. PubMed ID: 31748178
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Evacetrapib in Patients with Inadequately-controlled Hypercholesterolemia and High Cardiovascular Risk; A meta-analysis of Randomized Placebo-controlled Trials.
Bahbah EI; Shehata MSA; Alnahrawi SI; Sayed A; Menshawey A; Fisal A; Morsi M; Gabr ME; Elbasit MSA
Prostaglandins Leukot Essent Fatty Acids; 2021 May; 168():102282. PubMed ID: 33882411
[TBL] [Abstract][Full Text] [Related]
20. The impact of argan oil on plasma lipids in humans: Systematic review and meta-analysis of randomized controlled trials.
Ursoniu S; Sahebkar A; Serban MC; Banach M;
Phytother Res; 2018 Mar; 32(3):377-383. PubMed ID: 29130532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
